Navigation Links
Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint
Date:2/12/2008

aclitaxel alone.

About the BO17708 study

BO17708 is an international phase III trial which randomized 736 patients who did not receive previous chemotherapy for their metastatic breast cancer to one of three groups;

-- Avastin 7.5 mg/kg every 3 weeks in combination with docetaxel

-- Avastin 15 mg/kg every 3 weeks in combination with docetaxel

-- docetaxel + placebo as control arm

The primary objective of the study was to demonstrate superiority in progression-free survival of both Avastin containing treatment arms compared to the control arm. Secondary endpoints for the study included overall survival, response rate, duration of response, quality of life, safety and tolerability.

About Avastin

Data from the comprehensive Avastin cancer clinical development programme have resulted in approvals in advanced colorectal, breast, lung, and kidney cancer:

-- February 2004 (US) and January 2005 (EU) -- first-line treatment in

patients with metastatic colorectal cancer (CRC).

-- June 2006 (US) -- second-line treatment in patients with metastatic

CRC.

-- October 2006 (US) -- first-line treatment in patients with advanced

non-small cell lung cancer (NSCLC).

-- March 2007 (EU) -- first-line treatment in patients with metastatic

breast cancer.

-- April 2007 (Japan) -- treatment in patients with recurrent or advanced

CRC.

-- August 2007 (EU) -- first-line treatment in patients with advanced

NSCLC.

-- December 2007 (EU) -- first-line treatment in patients with advanced

RCC.

-- January 2008 (EU) -- first and later-line treatment in patients with

metastatic CRC in combination with any chemotherapy.

All trademarks used or mentioned in this release are legally protected.

Additional information

To access video clips about Avastin, in broadcast standard, free of charge, please go
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. Second Thoughts about Fluoride, Reports Scientific American
5. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
6. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
7. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
8. Immtech Reports Fiscal Second Quarter 2008 Results
9. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
10. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
11. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015  Boston Children,s Hospital physicians report the ... of their anatomy before undergoing high-risk brain procedures. ... in the brain,s blood vessels) that posed special ... the Journal of Neurosurgery: Pediatrics , the ... synthetic resins to create custom, high-fidelity models of ...
(Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... Pharmaceuticals, Inc. announced today that the first patient has ... MM-121, a fully human monoclonal antibody that targets ErbB3, ... with advanced solid tumors. (Logo: http://photos.prnewswire.com/prnh/20100913/NE63515LOGO) ... safety and pharmacokinetics of MM-121 when administered in combination ...
... Nov. 30, 2011  Safecor Health, the market leader ... have finalized a one-year extension  to their single-source ... and bar coding services.  Under the terms of ... to provide a comprehensive menu of unit-dose and ...
Cached Medicine Technology:Novation Extends Unit Dose Repackaging and Bar Coding Contract with Safecor Health 2
(Date:8/1/2015)... ... 01, 2015 , ... Brig and Lita Hart, icons of the network marketing ... Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been a ... have agreed to join their missions of purpose together to change the course of ...
(Date:8/1/2015)... Dallas, TX (PRWEB) , ... August 01, 2015 , ... ... support for the March4thforWellBeing foundation, making hers the very first small business donation to ... and look beautiful for over thirty years. Her legacy includes a complete line of ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic tickets for ... Arena. Fans of every genre of music will have an act they are excited ... of the festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reliable source for authentic tickets ... Grant Park. The festival will end on Sunday, August 2nd. , ... annual Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment ...
(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... time , , TUESDAY, Jan. 15 (HealthDay News) -- Foodborne illness can ... different pathogens. Here is a rundown of the most common bacterial ... E. COLI 0157:H7 , There are many strains ... coli. Most are harmless, four or five can cause disease, and ...
... drinks containing live bacteria, have a tangible effect on the ... today (Tuesday 15 January) in the journal Molecular Systems Biology. ... at how probiotics change the biochemistry of bugs known as ... an important part in a persons metabolic makeup. Different people ...
... Integrated Solutions Help Dearborn County Hospital Better Serve ... Area with Heightened Productivity and Collaboration, ... Dearborn County Hospital,in southeast Indiana, efficient yet responsive ... patients and patient,families. To boost care levels even ...
... Postmenopausal women who take combined estrogen/progestin hormone-replacement ... fourfold increased risk of developing various forms of ... researchers at Fred Hutchinson Cancer Research Center., Previous ... combined hormone-therapy use was necessary to increase overall ...
... feedback feature promotes a more informed health care ... and regional studies,indicate that informed patients make better ... is launching a member feedback feature in,Spring 2008 ... to share,information with each other about their provider ...
... Rivers,Pharmaceuticals, LLC finalized acquisition of the hepatitis C ... ). Valeant is,receiving $91 million from Three Rivers ... growing portfolio is very exciting," said,Donald J. Kerrish, ... purchase is only a beginning for Three Rivers, ...
Cached Medicine News:Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 2Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 3Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 4Health News:Probiotics affect metabolism, says new study 2Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 2Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 3Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 4Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 5Health News:Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use 2Health News:Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options 2Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2
ENDO STITCH™ Single Use Loading Units....
... single use suturing device has application ... of interrupted or running stitches in ... use suturing device is available in ... with the choice of 4 suture ...
... Suture Assistant is a sterile, single-patient-use instrument ... and in placing a suture and a ... button to tie a secure intracorporeal knot., ... the ENDOPATH 5mm trocars or larger trocars ...
... 42" long suture inserted into a plastic tube. ... and scored on the other. The suture protrudes ... ST-3 needle. The opposite end of the suture ... plastic tube. The scored end acts as the ...
Medicine Products: